THE ROLE OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL RESEARCH AND INSTITUTIONAL EDUCATION: CURRENT CHALLENGES AND FUTURE PROSPECTS
Abstract
Keywords: Artificial intelligence, Machine learning, Deep learning, Drug discovery, Pharmaceutical research, Clinical trials, Personalized medicine.
References
Topol, E. J. (2019), Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Basic Books.
Schneider, P. & Clark, D. E. (2020), AI in Drug Discovery. Royal Society of Chemistry.
Wong, C. H., Siah, K. W., & Lo, A. W. (2019), Estimation of clinical trial success rates and related parameters. Biostatistics, 20(2):273-286.
Mak, K. K., & Pichika, M. R. (2019), Artificial intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3):773-780.
Liu, X., Faes, L., Kale, A. U., Wagner, S. K., Fu, D. J., Bruynseels, A. & Keane, P. A. (2019), A comparison of deep learning performance against healthcare professionals in detecting diseases from medical imaging: A systematic review and meta-analysis. The Lancet Digital Health, 1(6):e271-e297.
Rajkomar, A., Dean, J. & Kohane, I. (2019), Machine learning in medicine. New England Journal of Medicine, 380(14):1347-1358.
Choudhury, A., Asan, O. (2020), Role of Artificial Intelligence in Patient Safety Outcomes: Systematic Literature Review. JMIR Medical Informatics, 8(7):e18599.
Fogel, A. L. & Kvedar, J. C. (2018), Artificial intelligence powers digital medicine. NPJ Digital Medicine, 1, 5.
Yang, G., et al. (2021), Artificial intelligence in drug discovery: applications and techniques. Computational and Structural Biotechnology Journal, 19:1427-1438.
European Medicines Agency (EMA). (2021). Reflection paper on artificial intelligence in medicine development. EMA Regulatory Guidelines.
Refbacks
- There are currently no refbacks.